Mikael Åström

The new orally active immunoregulator laquinimod (ABR-215062) effectively inhibits development and relapses of experimental autoimmune encephalomyelitis

Charlott Brunmark, Anna Runström, Lennart Ohlsson et al. · Journal of Neuroimmunology · 2002 · 165 citations

Immunogenetics, Autoimmune Disease, Immunology +8

Extended Release Quetiapine Fumarate Monotherapy in Major Depressive Disorder

Andrew J. Cutler, Stuart Montgomery, David Feifel et al. · The Journal of Clinical Psychiatry · 2009 · 136 citations

The Prevalence of Gallstone Disease in A Defined Cohort of Patients With Crohn's Disease

Annika Lapidus, Mårten Bångstad, Mikael Åström et al. · The American Journal of Gastroenterology · 1999 · 105 citations

Linomide reduces the rate of active lesions in relapsing-remitting multiple sclerosis

Oluf Andersen, Jan Lycke, P. O. Tollesson et al. · Neurology · 1996 · 102 citations

Neurological Disorder, Neurological Progress, Pharmacotherapy +18

Effect of 4 days of mouth rinsing with delmopinol or chlorhexidine on the vitality of plaque bacteria

J. Rundegren, Eva Bondesson Hvid, Maria Johansson et al. · Journal Of Clinical Periodontology · 1992 · 63 citations